Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment ; volume:76 ; number:6 ; day:29 ; month:8 ; year:2024 ; pages:1325-1332 ; date:12.2024
Pharmacological reports ; 76, Heft 6 (29.8.2024), 1325-1332, 12.2024
- Creator
-
Kwaśny, Aleksander
Cubała, Wiesław Jerzy
Włodarczyk, Adam
Pastuszak, Krzysztof
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s43440-024-00641-1
- URN
-
urn:nbn:de:101:1-2502072100523.824051155963
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kwaśny, Aleksander
- Cubała, Wiesław Jerzy
- Włodarczyk, Adam
- Pastuszak, Krzysztof
- SpringerLink (Online service)
Other Objects (12)
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression
Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression
Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression